Objectives: 1) To investigate whether attachment security, autonomy-connectedness, and childhood experiences moderate effects of social support during stress; 2) To investigate the influence of oxytocin on the ability to be close to others (in an…
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
stress reactiviteit
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Main study parameters/endpoints: The main outcome is stress reactivity
(self-reported stress and physiological reactivity) during the Trier social
stress test and Cold pressor test, as a function of oxytocin and social support
status. Oxytocin is hypothesized to moderate the stress-buffering effects of
social support. Another endpoint is interpersonal distance (distance between
participant and a virtual person)
Secondary outcome
Other moderators of the effect of oxytocin include attachment, parenting styles
and autonomy-connectedness.
Background summary
Rationale: Susceptibility for stress-related psychopathology, e.g. anxiety
disorders, may arise in part when individuals are not able to form stable,
long-lasting bonds, and to profit from the stress-buffering effects of social
support. Oxytocin has been shown to play an important role in attachment to
others and prosocial behaviour. However, it is yet unclear whether, how, and
for whom oxytocin may be used in a clinical setting, most notably because many
individual differences exist in the stress-buffering effects of oxytocin. We
hypothesize that oxytocin may increase the stress-buffering effects of social
support, but that this effect depends on individual variations in attachment,
parenting styles and autonomy-connectedness. These effects may also be more
pronounced in socially stressful situations, compared with a general stressor.
Further, in line with the hypothesis that interpersonal functioning is
essential for psychological well-being, this study tests whether oxytocin and
social support affect the interpersonal closeness one is comfortable with, and
whether this varies for different emotions of the other person. Individual
differences in attachment, parenting experiences during childhood and
autonomy-connectedness are hypothesized to influence preferred interpersonal
closeness and stress during this task.
Study objective
Objectives:
1) To investigate whether attachment security, autonomy-connectedness, and
childhood experiences moderate effects of social support during stress; 2) To
investigate the influence of oxytocin on the ability to be close to others (in
an interpersonal distance task); 3) To investigate the influence of oxytocin
and social support on stress and anxiety levels induced by a social stress test
(a virtual Trier Social Stress Test); 4) To investigate the influence of
oxytocin and social support on pain perception with a cold pressor test
Study design
Study design: A 2x2 experimental study, in which participants are randomly
assigned to 1) an oxytocin or placebo nasal spray, and 2) a social support
(bringing a friend) or no support condition. Participants complete a virtual
reality interpersonal closeness test, a virtual Trier Social Stress Test, and a
Cold Pressor Test. In between, measures of stress, cortisol, heart rate, blood
pressure and skin conductance are completed.
Intervention: Half of participants receive 6 puffs of an oxytocin nasal spray.
The other half receives an equivalent number of puffs of a placebo nasal spray.
Intervention
24 IU oxytocin or placebo nasal spray
Study burden and risks
Participants will spend approximately 30 minutes on filling out online
questionnaires before the lab session, and a maximum of 2 hours during the lab
session. Participants will be drawn from a psychology student sample, and will
be rewarded by participant credits. There are no risks in participating in this
experiment. Some emotional distress might occur during the stress tasks, but we
expect that the debriefing procedure will eliminate this stress after the tasks
have been performed.
Warandelaan 2
Tilburg 5037 AB
NL
Warandelaan 2
Tilburg 5037 AB
NL
Listed location countries
Age
Inclusion criteria
- Female
- Age 18-30
Exclusion criteria
Use of medication (except oral contraceptives), drug or alcohol abuse, psychiatric disorder, neurological or cardiovascular disease, nasal disease or obstruction, pregnancy, and breast feeding
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
EudraCT | EUCTR2017-000298-35-NL |
CCMO | NL60593.028.17 |
OMON | NL-OMON25216 |